• Ep. 196 Biodesign Insights: Embracing Risk and Innovation with Dr. Christopher Kinsella

  • Oct 25 2024
  • Length: 55 mins
  • Podcast

Ep. 196 Biodesign Insights: Embracing Risk and Innovation with Dr. Christopher Kinsella

  • Summary

  • Are you curious about the biotechnology startup world? Learn how our guest transitioned from trauma surgeon to entrepreneur in this episode of the BackTable Podcast. Dr. Chris Kinsella, CEO of Watershed Therapeutics and our host Dr. Bryan Hartley discuss the importance of using entrepreneurship to solve clinical needs. Watershed Therapeutics has created a novel bladder drug delivery platform to help women with recurrent urinary tract infections. --- SYNPOSIS The doctors systematically cover the process of identifying market needs, inventing solutions, bringing a product to the market, and managing risk. They also share examples of successful startup ventures and underscore the importance of perseverance, innovative thinking, and strategic market focus in forging a path to success. --- TIMESTAMPS 00:00 - Introduction 04:30 - The Birth of a Surgical Trainer 07:04 - Challenges and Innovations in Trauma Surgery 22:06 - Evaluating and Killing Ideas 28:27 - Challenging Assumptions 29:53 - Meeting a Co-Founder 33:07 - Developing the Solution 37:29 - Raising Funds 40:28 - Navigating Regulatory Challenges and Market Expansion --- RESOURCES Watershed Therapeutics: https://www.watershedtx.com/ Stanford Biodesign Innovation Fellowship: https://biodesign.stanford.edu/programs/fellowships/innovation-fellowships.html
    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Ep. 196 Biodesign Insights: Embracing Risk and Innovation with Dr. Christopher Kinsella

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.